Latest Distribution Channels News

DigitalX Limited reported a 32.8% increase in digital asset holdings to $72.9 million and raised $20.7 million to pivot its treasury strategy firmly towards Bitcoin. The DigitalX Bitcoin ETF (BTXX) also surged, nearing $53 million in assets under management.

EVE Health Group has completed its acquisition of Nextract, raised $1 million to fund manufacturing, and achieved key regulatory and commercial milestones for its pharmaceutical products targeting erectile dysfunction and dysmenorrhea.

Cluey Ltd has achieved its first-ever positive operating cash flow in Q4 FY25, marking a pivotal shift towards sustainable growth powered by AI innovation and expanded market reach.

Osteopore Limited has posted a record AUD 835K revenue in Q2 CY25, driven by strong APAC sales and new European market access following EU MDR clearance. The company also advances clinical trials and refreshes key distribution channels.

Peppermint Innovation Ltd reported robust growth in registered users, loan approvals, and transaction volumes in its June 2025 quarter, alongside strategic partnerships and key platform upgrades aimed at expanding financial inclusion in the Philippines.

Entertainment Rewards Ltd reports a 6.1% revenue increase in Q4 FY25, driven by growth in key programs and a new $2.5 million loan facility, while narrowing its operating loss.

N1 Holdings reports a profitable FY2025 with strategic expansion into Australia's largest aggregator panel and launches AI-driven credit tools to enhance SME lending operations.

Stealth Group Holdings reports a robust $6 million in pre-sales for iPhone 17 accessories, marking a 50% increase from last year and signaling strong momentum ahead of the global launch.

Plenti Group has reported a third consecutive record quarter with $437 million in loan originations, driven by strong automotive and NAB partnership growth. The fintech lender also secured a key government contract and continues to deliver low credit losses.

Tinybeans Group Limited has reported a second straight quarter of positive operating cash flow alongside steady subscriber growth and new product launches, signaling a turning point for the family-focused subscription platform.

Immuron Limited reports a robust 49% increase in FY25 global sales of its immune supplement Travelan, driven by strong growth in Australia and North America. The company plans to accelerate its North American market presence in FY26.

Biome Australia Limited has reported a 69% increase in international sales revenue for FY25, reaching $1.5 million, driven by new strategic distribution agreements across Ireland, New Zealand, and Canada.